awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26829101-11C9F33B-0D42-47C8-A406-3AA950B3E519
Q26829101-11C9F33B-0D42-47C8-A406-3AA950B3E519
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829101-11C9F33B-0D42-47C8-A406-3AA950B3E519
Antituberculosis therapy for 2012 and beyond
P2860
Q26829101-11C9F33B-0D42-47C8-A406-3AA950B3E519
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829101-11C9F33B-0D42-47C8-A406-3AA950B3E519
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b47f9a97eaf02c4a293d255dbe280c8a10b91166
P2860
Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.